Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies

摘要

Immunotherapy is revolutionizing the treatment of certain hematological malignancies and providing cure to patients even with some advanced diseases (eg, B-ALL, lymphoma). However, immunotherapy, especially cellular immunotherapy, is an emerging field and on-going research will have to address several issues to improve safety and efficacy of this novel treatment modality. There is also the need to extend the application to additional hematological malignancies. The EHA scientific working group for immunotherapy has defined major research questions for the future development of immunotherapy for patients with hematological malignancies.